theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hematology

Chemotherapy   

Questions discussed in this category


Does the presence of asparaginase antibodies on Granger Genetics testing indicate need to switch asparaginase formulations?
1 Answer available

What is your approach to management of chronic neutropenia in a patient with Sjogren’s who was recently diagnosed with metastatic endometrial cancer and plans to start chemotherapy?
ANC <500
1 Answer available

When using daratumumab in the setting of post-transplant red cell aplasia or post-transplant immune-mediated cytopenias, do you hold the drug for certain ANC parameters?
1 Answer available
176021718213630


Papers discussed in this category


Mediterranean journal of rheumatology, 2022 Mar 31
Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren's Syndrome.

Pediatric blood & cancer, 2015-06
Clinical application of asparaginase activity levels following treatment with pegaspargase.

Leukemia & lymphoma, 2018-08
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.

Haematologica, 2016 Mar
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation.

Related Topics in Hematology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.